SMTI

SEC source: 0001493152-24-023959 · ownership.xml · nonDerivative · entry 1

DeSutter Robert Andrew · CIK 0001828759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,455

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date.

SEC source: 0001493152-24-023956 · ownership.xml · nonDerivative · entry 1

Major Eric D · CIK 0001605497 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,109

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date.

SEC source: 0001493152-24-014961 · ownership.xml · nonDerivative · entry 1

Waldrop Jacob A. · CIK 0002017814 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,101

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in two equal installments, with one-half of the shares vesting on April 15, 2025 and 2026, respectively.

SEC source: 0001493152-24-009564 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,854

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 7, 2025, 2026 and 2027, respectively.

SEC source: 0001493152-24-009563 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,998

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 7, 2025, 2026 and 2027, respectively.

SEC source: 0001493152-24-008909 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,161

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,329 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,329 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-008909 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,951

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,944 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,944 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-008907 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,348

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,405 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,405 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-008907 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,947

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-004972 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,877

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-004970 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,634

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,036 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,036 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-000291 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,304

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on January 1, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on January 1, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-033453 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,559

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,736 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,736 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-020175 · ownership.xml · nonDerivative · entry 1

TANZBERGER ERIC D · CIK 0001243196 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,300

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020182 · ownership.xml · nonDerivative · entry 1

DeSutter Robert Andrew · CIK 0001828759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,523

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020176 · ownership.xml · nonDerivative · entry 1

STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 836,778

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020178 · ownership.xml · nonDerivative · entry 1

Ortwein Sara N · CIK 0001688411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,082

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020180 · ownership.xml · nonDerivative · entry 1

Major Eric D · CIK 0001605497 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,669

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020179 · ownership.xml · nonDerivative · entry 2

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,696

F2 · shares: Represents shares of restricted stock granted by the Company to the reporting person pursuant to the Sanara MedTech Inc. 2014 LTIP. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020179 · ownership.xml · nonDerivative · entry 1

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,888

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated (the "2014 LTIP"). The shares of restricted stock vested in full on the date of grant.

SEC source: 0001493152-23-020177 · ownership.xml · nonDerivative · entry 1

Salamone Ann Beal · CIK 0001799659 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,946

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-020181 · ownership.xml · nonDerivative · entry 1

Mack Roszell III · CIK 0001899402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,497

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-23-012318 · ownership.xml · derivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2023-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the terms of the option award agreement, the option vested in full on March 15, 2019 in connection with the closing of the Share Exchange Agreement between the issuer and CGI Cellerate RX, LLC, which was deemed to be a change of control of the issuer.

SEC source: 0001493152-23-012318 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 4

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,243

F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,943 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F4 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,943 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,960

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,285

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on December 9, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on December 9, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,097

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008368 · ownership.xml · nonDerivative · entry 1

McMahon Rebecca E · CIK 0001872457 · President - R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,595

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 682 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 682 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 3

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,025

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,557

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,810

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,699 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,699 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-006861 · ownership.xml · nonDerivative · entry 1

McMahon Rebecca E · CIK 0001872457 · President - R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,796

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2024, 2025 and 2026, respectively.

SEC source: 0001493152-23-006857 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,468

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2024, 2025 and 2026, respectively.

SEC source: 0001493152-23-006855 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,198

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in full on September 1, 2023.

SEC source: 0001493152-23-006855 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,462

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2024, 2025 and 2026, respectively.

SEC source: 0001493152-22-034634 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,474

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034634 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,799

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 6,035 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 6,035 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 5

Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,469

F5 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.

F5 · price: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.

SEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 4

Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,883

F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F4 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 3

Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,143

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 2

Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,225

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 1

Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,326

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034630 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,251

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034630 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,504

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-031349 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,270

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-030994 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,687

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-030674 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,250

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-026823 · ownership.xml · nonDerivative · entry 2

Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,550

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.20 to $29.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

SEC source: 0001493152-22-026823 · ownership.xml · nonDerivative · entry 1

Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,890

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.185 to $28.10, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.